Changes in Inflammatory Chemokine and Cytokine Levels from Normotension to Hypertensive Heart Disease

Falak Sehar Sahito1,2, Ghazala Yasmeen3, Muhammad Tariq Farman

  • 1Department of Physiology, Dow International Medical College, Ojha Campus, Dow University of Health Sciences, Karachi, Pakistan.

Insights

This study found distinct inflammatory cytokine profiles in hypertension and hypertensive heart disease. Elevated CCL2 and Interferon-gamma (IFN-γ) were linked to hypertension, while CCR2 and XCL1 levels differed across groups.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Biochemistry

Background:

  • Essential hypertension is a complex condition with significant cardiovascular implications.
  • Inflammatory cytokines, including Chemokine CCL2 (MCP-1), its receptor CCR2, XCL1, and Interferon-gamma (IFN-γ), are implicated in cardiovascular pathophysiology.
  • Understanding cytokine profiles may offer insights into disease mechanisms and progression.

Purpose of the Study:

  • To investigate the association between serum levels of CCL2, CCR2, XCL1, and IFN-γ and normotension, hypertension, and hypertensive heart disease (HHD).
  • To determine if combined cytokine profiles can differentiate between these cardiovascular states.

Main Methods:

  • A comparative cross-sectional study involving 150 participants (50 per group: normotensive, hypertensive, HHD) aged 30-60 years.
  • Serum cytokine levels (CCL2, CCR2, XCL1, IFN-γ) were quantified using enzyme-linked immunosorbent assay.
  • Statistical analyses included ANOVA, Pearson's correlation, and discriminant analysis to assess group differences and classification accuracy.

Main Results:

  • Serum levels of CCL2 and IFN-γ were significantly higher in the hypertensive group compared to normotensive and HHD groups (p <0.01).
  • CCR2 and XCL1 levels were lower in hypertensive and HHD groups relative to the normotensive group (p <0.01).
  • A four-cytokine discriminant model achieved 76% accuracy in classifying participants across the study groups.

Conclusions:

  • Distinct inflammatory cytokine profiles are associated with normotension, hypertension, and hypertensive heart disease.
  • The observed inflammatory heterogeneity highlights the complex nature of hypertensive disease.
  • These findings provide a basis for future longitudinal research into hypertensive conditions.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...